Emergex collaborates with nonprofit organization to advance yellow fever booster vaccine candidate April 7, 2022
Peptidomimetic TMPRSS2 inhibitor shows prophylactic and therapeutic activity against SARS-CoV-2 VOCs April 7, 2022